Share Price and Basic Stock Data
Last Updated: January 17, 2026, 7:30 am
| PEG Ratio | 0.61 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Narmada Agrobase Ltd operates within the animal feed sector, specifically focusing on shrimp feed. As of the latest reporting, the company’s stock price stood at ₹27.3 with a market capitalization of ₹103 Cr. The company has shown considerable fluctuations in its quarterly sales. For instance, sales recorded ₹13.24 Cr in September 2022, dipped to ₹10.62 Cr in December 2022, and surged to ₹18.26 Cr by March 2023. However, subsequent quarters witnessed a decline, with sales dropping to ₹7.95 Cr in June 2023 before rebounding to ₹11.41 Cr in September 2023. The trailing twelve-month (TTM) revenue reached ₹66.17 Cr, reflecting a steady upward trajectory compared to the ₹49.48 Cr reported for the fiscal year ending March 2023. This growth showcases Narmada Agrobase’s potential to capitalize on increasing demand within the aquaculture sector, which is expected to grow significantly in the coming years.
Profitability and Efficiency Metrics
Narmada Agrobase’s profitability metrics reveal a mixed performance. The company reported a net profit of ₹4.09 Cr for the fiscal year ending March 2025, which is a substantial increase from ₹0.65 Cr in March 2023. The operating profit margin (OPM) improved significantly, rising to 8.63% for the fiscal year 2025 from 4.08% in 2023. However, the OPM remains lower compared to the industry average, which typically hovers around 10-15% for similar companies in the animal feed sector. The return on equity (ROE) stood at 11.2%, while return on capital employed (ROCE) reported a commendable 13.05%. Despite these positive indicators, the company’s cash conversion cycle (CCC) of 260.66 days raises concerns regarding operational efficiency, as it exceeds the typical sector benchmark of 100-150 days, potentially indicating liquidity challenges.
Balance Sheet Strength and Financial Ratios
Narmada Agrobase’s balance sheet reflects a cautious yet improving financial position. The company’s total liabilities reported at ₹70.72 Cr, with borrowings amounting to ₹10.53 Cr, suggest a manageable debt level relative to its equity capital of ₹37.94 Cr. The interest coverage ratio (ICR) is notably strong at 7.44x, indicating that the company can comfortably meet its interest obligations. The current ratio of 6.21x signifies robust short-term liquidity, well above the standard threshold of 1.5x. However, the price-to-book value (P/BV) ratio at 1.11x is indicative of a premium valuation compared to typical sector averages, which may suggest overvaluation risks. The company also holds ₹19.98 Cr in reserves, enhancing its financial cushion for future investments and contingencies.
Shareholding Pattern and Investor Confidence
Narmada Agrobase’s shareholding structure reveals a significant presence of promoters, who hold 50.30% of the equity as of September 2025. This level of promoter ownership generally instills investor confidence, reflecting a vested interest in the company’s long-term success. The public shareholding stands at 40.74%, while domestic institutional investors (DIIs) hold 8.96%. The gradual decline in promoter shareholding from 66.47% in December 2022 to the current level may raise questions about their commitment; however, the increase in public and DII participation suggests growing interest from external investors. The total number of shareholders has also increased significantly from 881 in December 2022 to 11,308 in September 2025, indicating rising investor interest in the company.
Outlook, Risks, and Final Insight
Narmada Agrobase demonstrates promising growth potential, particularly due to its focus on the expanding shrimp feed market. However, the company faces several risks, including operational inefficiencies as indicated by the high cash conversion cycle and fluctuating sales patterns. Additionally, the declining promoter stake could signal potential governance issues that may affect investor sentiment. The outlook remains cautiously optimistic; if the company can effectively manage its operational challenges and leverage its strong liquidity position, it has the potential to capitalize on market opportunities. Conversely, any significant downturn in demand for shrimp feed or increased competition could pose substantial threats to profitability. Overall, Narmada Agrobase’s ability to adapt and innovate in a dynamic market will be crucial for its sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 105 Cr. | 27.6 | 28.4/14.6 | 27.4 | 15.3 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 10,387 Cr. | 540 | 876/538 | 23.9 | 94.1 | 2.04 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 10,979 Cr. | 806 | 965/582 | 17.8 | 221 | 1.12 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 69.4 Cr. | 4.03 | 8.17/3.90 | 17.4 | 5.21 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 7,157.00 Cr | 344.41 | 21.63 | 83.90 | 0.79% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.24 | 10.62 | 18.26 | 7.95 | 11.41 | 12.22 | 18.75 | 12.26 | 10.28 | 13.84 | 29.30 | 11.08 | 11.95 |
| Expenses | 12.61 | 10.06 | 17.81 | 7.50 | 10.94 | 11.77 | 17.60 | 10.68 | 8.21 | 12.50 | 28.71 | 9.76 | 10.65 |
| Operating Profit | 0.63 | 0.56 | 0.45 | 0.45 | 0.47 | 0.45 | 1.15 | 1.58 | 2.07 | 1.34 | 0.59 | 1.32 | 1.30 |
| OPM % | 4.76% | 5.27% | 2.46% | 5.66% | 4.12% | 3.68% | 6.13% | 12.89% | 20.14% | 9.68% | 2.01% | 11.91% | 10.88% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 | 0.01 | 0.32 | 0.32 | 0.33 | 0.33 |
| Interest | 0.19 | 0.22 | 0.25 | 0.23 | 0.23 | 0.23 | 0.26 | 0.24 | 0.24 | 0.21 | 0.16 | 0.24 | 0.20 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 |
| Profit before tax | 0.37 | 0.27 | 0.13 | 0.16 | 0.20 | 0.17 | 0.82 | 1.29 | 1.78 | 1.39 | 0.69 | 1.36 | 1.38 |
| Tax % | 27.03% | 25.93% | 23.08% | 31.25% | 15.00% | 23.53% | 25.61% | 21.71% | 26.97% | 28.06% | -13.04% | 25.00% | 25.36% |
| Net Profit | 0.27 | 0.20 | 0.10 | 0.11 | 0.17 | 0.13 | 0.61 | 1.02 | 1.29 | 1.00 | 0.78 | 1.02 | 1.03 |
| EPS in Rs | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.16 | 0.27 | 0.34 | 0.26 | 0.21 | 0.27 | 0.27 |
Last Updated: January 11, 2026, 7:47 am
Below is a detailed analysis of the quarterly data for Narmada Agrobase Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 11.95 Cr.. The value appears strong and on an upward trend. It has increased from 11.08 Cr. (Jun 2025) to 11.95 Cr., marking an increase of 0.87 Cr..
- For Expenses, as of Sep 2025, the value is 10.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.76 Cr. (Jun 2025) to 10.65 Cr., marking an increase of 0.89 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.30 Cr.. The value appears to be declining and may need further review. It has decreased from 1.32 Cr. (Jun 2025) to 1.30 Cr., marking a decrease of 0.02 Cr..
- For OPM %, as of Sep 2025, the value is 10.88%. The value appears to be declining and may need further review. It has decreased from 11.91% (Jun 2025) to 10.88%, marking a decrease of 1.03%.
- For Other Income, as of Sep 2025, the value is 0.33 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.33 Cr..
- For Interest, as of Sep 2025, the value is 0.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.24 Cr. (Jun 2025) to 0.20 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.38 Cr.. The value appears strong and on an upward trend. It has increased from 1.36 Cr. (Jun 2025) to 1.38 Cr., marking an increase of 0.02 Cr..
- For Tax %, as of Sep 2025, the value is 25.36%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 25.36%, marking an increase of 0.36%.
- For Net Profit, as of Sep 2025, the value is 1.03 Cr.. The value appears strong and on an upward trend. It has increased from 1.02 Cr. (Jun 2025) to 1.03 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.27. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:55 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.97 | 30.53 | 34.45 | 37.00 | 47.50 | 61.46 | 58.14 | 34.61 | 49.48 | 49.74 | 64.68 | 66.17 |
| Expenses | 21.12 | 29.35 | 33.02 | 35.43 | 45.87 | 59.00 | 55.90 | 32.61 | 47.46 | 47.22 | 59.10 | 61.62 |
| Operating Profit | 0.85 | 1.18 | 1.43 | 1.57 | 1.63 | 2.46 | 2.24 | 2.00 | 2.02 | 2.52 | 5.58 | 4.55 |
| OPM % | 3.87% | 3.87% | 4.15% | 4.24% | 3.43% | 4.00% | 3.85% | 5.78% | 4.08% | 5.07% | 8.63% | 6.88% |
| Other Income | 0.02 | 0.02 | 0.02 | 0.07 | 0.28 | 0.03 | 0.04 | 0.06 | 0.05 | 0.07 | 0.66 | 1.30 |
| Interest | 0.43 | 0.70 | 0.75 | 0.82 | 0.70 | 1.03 | 0.85 | 0.82 | 0.86 | 0.96 | 0.84 | 0.81 |
| Depreciation | 0.27 | 0.27 | 0.30 | 0.28 | 0.54 | 0.40 | 0.42 | 0.37 | 0.32 | 0.28 | 0.24 | 0.22 |
| Profit before tax | 0.17 | 0.23 | 0.40 | 0.54 | 0.67 | 1.06 | 1.01 | 0.87 | 0.89 | 1.35 | 5.16 | 4.82 |
| Tax % | 17.65% | 21.74% | 25.00% | 25.93% | 25.37% | 25.47% | 32.67% | 31.03% | 26.97% | 24.44% | 20.74% | |
| Net Profit | 0.14 | 0.19 | 0.30 | 0.40 | 0.50 | 0.79 | 0.68 | 0.61 | 0.65 | 1.02 | 4.09 | 3.83 |
| EPS in Rs | 0.22 | 0.21 | 0.33 | 0.15 | 0.13 | 0.21 | 0.18 | 0.16 | 0.17 | 0.27 | 1.08 | 1.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 15.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 35.71% | 57.89% | 33.33% | 25.00% | 58.00% | -13.92% | -10.29% | 6.56% | 56.92% | 300.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.18% | -24.56% | -8.33% | 33.00% | -71.92% | 3.63% | 16.85% | 50.37% | 244.06% |
Narmada Agrobase Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 39% |
| 3 Years: | 89% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 10% |
| 1 Year: | 31% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:42 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.83 | 1.83 | 5.19 | 7.53 | 13.55 | 13.55 | 13.55 | 13.55 | 13.55 | 37.94 | 37.94 |
| Reserves | 0.11 | 0.30 | 0.64 | 0.42 | 6.04 | 0.71 | 1.39 | 1.68 | 2.33 | 3.35 | 17.93 | 19.98 |
| Borrowings | 6.71 | 7.93 | 10.22 | 7.39 | 9.13 | 8.44 | 8.69 | 9.72 | 10.07 | 9.68 | 9.47 | 10.53 |
| Other Liabilities | 0.89 | 0.67 | 0.98 | 1.44 | 0.88 | 1.57 | 3.29 | 1.55 | 1.37 | 1.38 | 1.12 | 2.27 |
| Total Liabilities | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 | 70.72 |
| Fixed Assets | 2.38 | 2.71 | 2.66 | 2.74 | 4.66 | 3.89 | 3.50 | 3.75 | 3.44 | 3.18 | 2.97 | 2.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Investments | 0.21 | 0.21 | 0.43 | 0.47 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 |
| Other Assets | 6.37 | 7.81 | 10.58 | 11.23 | 18.31 | 20.38 | 23.42 | 22.75 | 23.88 | 24.78 | 63.47 | 67.49 |
| Total Assets | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 | 70.72 |
Below is a detailed analysis of the balance sheet data for Narmada Agrobase Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 37.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 37.94 Cr..
- For Reserves, as of Sep 2025, the value is 19.98 Cr.. The value appears strong and on an upward trend. It has increased from 17.93 Cr. (Mar 2025) to 19.98 Cr., marking an increase of 2.05 Cr..
- For Borrowings, as of Sep 2025, the value is 10.53 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.47 Cr. (Mar 2025) to 10.53 Cr., marking an increase of 1.06 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.12 Cr. (Mar 2025) to 2.27 Cr., marking an increase of 1.15 Cr..
- For Total Liabilities, as of Sep 2025, the value is 70.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.46 Cr. (Mar 2025) to 70.72 Cr., marking an increase of 4.26 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.98 Cr.. The value appears strong and on an upward trend. It has increased from 2.97 Cr. (Mar 2025) to 2.98 Cr., marking an increase of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Investments, as of Sep 2025, the value is 0.25 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.25 Cr., marking an increase of 0.25 Cr..
- For Other Assets, as of Sep 2025, the value is 67.49 Cr.. The value appears strong and on an upward trend. It has increased from 63.47 Cr. (Mar 2025) to 67.49 Cr., marking an increase of 4.02 Cr..
- For Total Assets, as of Sep 2025, the value is 70.72 Cr.. The value appears strong and on an upward trend. It has increased from 66.46 Cr. (Mar 2025) to 70.72 Cr., marking an increase of 4.26 Cr..
Notably, the Reserves (19.98 Cr.) exceed the Borrowings (10.53 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.86 | -6.75 | -8.79 | -5.82 | -7.50 | -5.98 | -6.45 | -7.72 | -8.05 | -7.16 | -3.89 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30.07 | 26.66 | 31.89 | 31.07 | 58.02 | 67.41 | 101.83 | 151.97 | 97.52 | 97.74 | 107.56 |
| Inventory Days | 73.60 | 54.43 | 70.88 | 75.62 | 70.33 | 37.81 | 28.83 | 77.66 | 75.95 | 84.67 | 154.49 |
| Days Payable | 10.54 | 6.97 | 8.63 | 11.98 | 3.54 | 4.02 | 15.92 | 10.03 | 7.25 | 6.35 | 1.38 |
| Cash Conversion Cycle | 93.13 | 74.11 | 94.14 | 94.71 | 124.80 | 101.19 | 114.74 | 219.59 | 166.22 | 176.06 | 260.66 |
| Working Capital Days | 21.27 | 25.70 | 26.81 | 25.35 | 59.01 | 53.09 | 64.10 | 104.62 | 87.34 | 94.00 | 194.58 |
| ROCE % | 10.26% | 10.11% | 10.59% | 7.68% | 9.21% | 8.20% | 6.96% | 6.88% | 8.79% | 13.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Diluted EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Cash EPS (Rs.) | 1.14 | 0.95 | 0.71 | 0.67 | 0.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Revenue From Operations / Share (Rs.) | 17.31 | 37.14 | 36.92 | 25.81 | 43.00 |
| PBDIT / Share (Rs.) | 1.64 | 1.91 | 1.53 | 1.46 | 1.68 |
| PBIT / Share (Rs.) | 1.58 | 1.71 | 1.29 | 1.19 | 1.37 |
| PBT / Share (Rs.) | 1.36 | 0.99 | 0.65 | 0.58 | 0.74 |
| Net Profit / Share (Rs.) | 1.08 | 0.75 | 0.48 | 0.40 | 0.55 |
| PBDIT Margin (%) | 9.49 | 5.14 | 4.13 | 5.64 | 3.91 |
| PBIT Margin (%) | 9.12 | 4.59 | 3.50 | 4.59 | 3.19 |
| PBT Margin (%) | 7.85 | 2.68 | 1.77 | 2.27 | 1.73 |
| Net Profit Margin (%) | 6.22 | 2.02 | 1.30 | 1.57 | 1.29 |
| Return on Networth / Equity (%) | 7.31 | 6.03 | 4.10 | 3.55 | 5.04 |
| Return on Capital Employeed (%) | 10.51 | 13.60 | 10.65 | 10.29 | 11.67 |
| Return On Assets (%) | 6.15 | 3.64 | 2.38 | 2.04 | 2.80 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.03 | 0.00 | 0.05 |
| Total Debt / Equity (X) | 0.16 | 0.57 | 0.63 | 0.62 | 0.53 |
| Asset Turnover Ratio (%) | 1.39 | 1.82 | 1.85 | 1.30 | 2.29 |
| Current Ratio (X) | 6.21 | 2.24 | 2.14 | 1.97 | 1.96 |
| Quick Ratio (X) | 3.73 | 1.33 | 1.31 | 1.41 | 1.59 |
| Inventory Turnover Ratio (X) | 3.93 | 5.29 | 5.67 | 5.72 | 10.22 |
| Interest Coverage Ratio (X) | 7.44 | 2.70 | 2.40 | 2.43 | 2.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.88 | 2.06 | 1.76 | 1.68 | 1.88 |
| Enterprise Value (Cr.) | 56.46 | 36.45 | 40.59 | 36.04 | 21.25 |
| EV / Net Operating Revenue (X) | 0.85 | 0.72 | 0.81 | 1.03 | 0.36 |
| EV / EBITDA (X) | 9.05 | 14.08 | 19.62 | 18.26 | 9.31 |
| MarketCap / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| Price / BV (X) | 1.11 | 1.63 | 1.96 | 1.74 | 0.92 |
| Price / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| EarningsYield | 0.06 | 0.03 | 0.02 | 0.02 | 0.05 |
After reviewing the key financial ratios for Narmada Agrobase Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 24) to 1.14, marking an increase of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.31. It has decreased from 37.14 (Mar 24) to 17.31, marking a decrease of 19.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 24) to 1.64, marking a decrease of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.71 (Mar 24) to 1.58, marking a decrease of 0.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.36, marking an increase of 0.37.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.75 (Mar 24) to 1.08, marking an increase of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 10. It has increased from 5.14 (Mar 24) to 9.49, marking an increase of 4.35.
- For PBIT Margin (%), as of Mar 25, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 4.59 (Mar 24) to 9.12, marking an increase of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 2.68 (Mar 24) to 7.85, marking an increase of 5.17.
- For Net Profit Margin (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 6.22, marking an increase of 4.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.31. This value is below the healthy minimum of 15. It has increased from 6.03 (Mar 24) to 7.31, marking an increase of 1.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 13.60 (Mar 24) to 10.51, marking a decrease of 3.09.
- For Return On Assets (%), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 6.15, marking an increase of 2.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.57 (Mar 24) to 0.16, marking a decrease of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.82 (Mar 24) to 1.39, marking a decrease of 0.43.
- For Current Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 3. It has increased from 2.24 (Mar 24) to 6.21, marking an increase of 3.97.
- For Quick Ratio (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.73, marking an increase of 2.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.93. This value is below the healthy minimum of 4. It has decreased from 5.29 (Mar 24) to 3.93, marking a decrease of 1.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.44. This value is within the healthy range. It has increased from 2.70 (Mar 24) to 7.44, marking an increase of 4.74.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 5.88, marking an increase of 3.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 56.46. It has increased from 36.45 (Mar 24) to 56.46, marking an increase of 20.01.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.85, marking an increase of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.05. This value is within the healthy range. It has decreased from 14.08 (Mar 24) to 9.05, marking a decrease of 5.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For Price / BV (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.11, marking a decrease of 0.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narmada Agrobase Ltd:
- Net Profit Margin: 6.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.51% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.31% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.4 (Industry average Stock P/E: 21.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | 613/P-1, IJ Pura (Jethaji) Dhanpura Road, Mehsana Gujarat 384421 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Neerajkumar Sureshchandra Agrawal | Managing Director |
| Mr. Suresh Chandra Gupta | Whole Time Director |
| Ms. Pooja Aidasani | Ind. Non-Executive Director |
| Mr. Ganesh Bhavarlal Prajapati | Ind. Non-Executive Director |
| Mr. Deepak Soni | Ind. Non-Executive Director |
| Ms. Shweta Vivek Nathwani | Non Exe. Women Independent Director |
FAQ
What is the intrinsic value of Narmada Agrobase Ltd?
Narmada Agrobase Ltd's intrinsic value (as of 18 January 2026) is ₹55.38 which is 100.65% higher the current market price of ₹27.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹105 Cr. market cap, FY2025-2026 high/low of ₹28.4/14.6, reserves of ₹19.98 Cr, and liabilities of ₹70.72 Cr.
What is the Market Cap of Narmada Agrobase Ltd?
The Market Cap of Narmada Agrobase Ltd is 105 Cr..
What is the current Stock Price of Narmada Agrobase Ltd as on 18 January 2026?
The current stock price of Narmada Agrobase Ltd as on 18 January 2026 is ₹27.6.
What is the High / Low of Narmada Agrobase Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narmada Agrobase Ltd stocks is ₹28.4/14.6.
What is the Stock P/E of Narmada Agrobase Ltd?
The Stock P/E of Narmada Agrobase Ltd is 27.4.
What is the Book Value of Narmada Agrobase Ltd?
The Book Value of Narmada Agrobase Ltd is 15.3.
What is the Dividend Yield of Narmada Agrobase Ltd?
The Dividend Yield of Narmada Agrobase Ltd is 0.00 %.
What is the ROCE of Narmada Agrobase Ltd?
The ROCE of Narmada Agrobase Ltd is 13.0 %.
What is the ROE of Narmada Agrobase Ltd?
The ROE of Narmada Agrobase Ltd is 11.2 %.
What is the Face Value of Narmada Agrobase Ltd?
The Face Value of Narmada Agrobase Ltd is 10.0.